STOCKS TELEGRAPH

Tag: Adamas stock

  • Early Morning Vibes: The 4 Best Stocks To Buy Now

    Early Morning Vibes: The 4 Best Stocks To Buy Now

    Futures for major US stock indices are growing rapidly on Monday – on the first day of February, a correction is planned on the American markets after a noticeable decline on Friday, according to trading data.

    The dynamics of futures on Monday indicates that stock markets may start February with corrective gains after the major US stock indexes lost around 2% on Friday. The sell-off occurred on fears of abnormal volatility in the prices of individual stocks and some assets.

    In general, analysts expect continued growth in the stock markets on optimism with regard to the prospects for the economy.

    In this light, traders are waiting for new macro statistics. So, in the first hours of major trading on Monday, the American Institute for Supply Management (ISM) will publish the index of business activity in the US industry (ISM Manufacturing) in January. Experts believe that the figure dropped to 60% against 60.5% in December.

    In addition, investors continue to follow the corporate reporting season in the US: 111 companies from the S&P 500 will report this week. In particular, the markets are awaiting with interest the quarterly financial results of such large technology companies as Amazon and Alphabet, which will present their financial results after the closing of Tuesday trading.

    Today Top Movers

    Tuscan Holdings Corp (THCB) gained over 55.24% at $24.15 in pre-market ‎trading on Monday.‎‎

    ‎Sos Ltd (SOS) grew over 6.57% at $3.24 in pre-market trading ‎today.‎ The company recently revealed the development of cutting-edge series of security systems based on Blockchain and AI technology competing the initial phase of its Blockchain strategy.‎

    ‎Sundial Growers Inc (SNDL) stock moved up 8.53 percent to $0.88 in the pre-market ‎trading following the declaration of US$100 million registered offering.‎

    ‎Adamas Pharma (ADMS) is up more than 24.37% at $7.35 in pre-market ‎hours ‎Monday ‎February 01, 2021.‎‎

    Top Upgrades & Downgrades

    JP Morgan turned bullish on Anterix Inc. (ATEX), upgrading the stock to “Neutral” and assigning a $40.0 price target, representing potential upside of 10.23% from Friday’s close.

    PagSeguro Digital Ltd. (PAGS) has won the favor of JP Morgan’s equity research team. The firm upgraded the shares from Neutral to Overweight and moved their price target to $61.0, suggesting 24.62% additional upside for the stock.

    Nikola Corporation (NKLA) received an upgrade from analysts at Wedbush, who also set their one-year price target on the stock to $25.0. They changed their rating on NKLA to Neutral from Underperform in a recently issued research note.

    Earlier Monday KeyBanc reduced its rating on Lowe’s Companies Inc. (LOW) stock to Sector Weight from Overweight.

    KeyBanc analysts reduced their investment ratings, saying in research reports covered by the media that its rating for Heartland Express Inc. (HTLD) has been changed to Sector Weight from Overweight.

    Analysts at KeyBanc downgraded Bed Bath & Beyond Inc. (BBBY)’s stock to Underweight from Sector Weight Monday.

    Latest Insider Activity

    AMC Entertainment Holdings Inc. (AMC) Director Silver Lake Group, L.L.C. announced the sale of shares taking place on Jan 27 at $16.05 for some 33,317,145 shares. The total came to more than $534.75 million.

    Gran Tierra Energy Inc. (GTE) 10% Owner GMT CAPITAL CORP sold on Jan 28 a total of 58,808,029 shares at $0.63 on average. The insider’s sale generated proceeds of almost $1.18 million. 

    FuelCell Energy Inc. (FCEL) CEO Few Jason declared the purchase of shares taking place on Jan 25 at $17.99 for some 11,000 shares. The transaction amount was around $0.2 million. 

    Intel Corporation (INTC) Chief Financial Officer Davis George S bought on Jan 26 a total 76,823 shares at $55.34 on average. The purchase cost the insider an estimated $503,317.

    Important Earnings

    Top US earnings releases scheduled for today include Otis Worldwide Corporation (NYSE: OTIS). It will announce its Dec 2020 financial results. The company is expected to report earnings of $0.59 per share from revenues of $3.36B in the three-month period. 

    Analysts expect ON Semiconductor Corporation (NASDAQ: ON) to report a net income (adjusted) of $0.28 per share when the bank releases its quarterly results shortly. Revenue for the fiscal quarter ended Dec 2020 is predicted to come in at $1.36B. 

    NXP Semiconductors N.V. (NXPI), due to announce earnings after the market closes today, is expected to report earnings of $2.1 per share from revenues of $2.46B recently concluded three-month period.

  • Early Morning Vibes: Top 4 Stocks To Buy Right Now

    Early Morning Vibes: Top 4 Stocks To Buy Right Now

    The Nasdaq Composite and S&P 500 stocks closed at record highs on Monday amid fluctuations in technology stocks, while investors awaited the release of multiple financial reports.

    The Nasdaq rose 92.93 points, or 0.7%, to 13635.99 points at the end of the volatile session. The index jumped 1.4% early in the day, then dropped 1.3% and then recovered. At the same time, there were no clear catalysts for such dynamics of the index.

    The S&P 500 added 13.89 points, or 0.4%, to 3855.36 points. The Dow Jones Industrial Average fell 36.98 points, or 0.1%, to 30960.00 points. Investors are worried about disruptions in the supply of Covid-19 vaccines. Pharmaceutical giant Merck has announced that it is ending work on a Covid-19 vaccine due to disappointing test results. Thus, a major participant dropped out of the race to create an effective vaccine. Meanwhile, its competitor, AstraZeneca, warned on Friday that shipments of its vaccine to the European Union would fall short of forecast.

    Vaccination problems and the spread of new strains of coronavirus have contributed to the recent rally in technology stocks. Tech corporations should benefit from this situation, as companies and employees who have switched to telecommuting are increasingly using digital technology.

    Corporate News

    Tech stocks were volatile. Apple shares gained 2.8%. Shares of data scientist Palantir Technologies, which is due to present its software on Tuesday, jumped 11.0% after posting a 21.0% gain throughout the day.

    Twitter and Etsy were down 0.5% and 2.2%, respectively, while rallying in early trading. Among the outsiders in the United States were also shares of financial and oil and gas companies. Chevron lost 0.9%, Goldman Sachs – 2.2%, which affected the DJIA.

    Meanwhile, shares of Kimberly Clark, a maker of Kleenex wipes and Huggies diapers, rose 3.3% after it forecast net sales to rise in 2021. It also raised its quarterly dividend and announced a new $ 5 billion share buyback program. Shares of special-purpose M&A firm TS Innovation Acquisitions, part of the Tishman Speyer real estate group, jumped 44.0%.
     The yield on the 10-year US Treasury bond fell from 1.090% on Friday to 1.038%.

    Today Top Movers

    Adamas Pharma (ADMS), a drug manufacturer company, soared about 15.35% ‎at $5.86 in pre-market ‎trading Tuesday. The FDA decision on the expanded use of Adamas Pharma’s lead drug GOCOVRI is expected on February 1, 2021.‎

    ‎Arcimoto Inc (FUV) share price jumped 2.29% to $21.85 during the early morning ‎trading session on ‎Tuesday after the company revealed that it has reached an agreement to acquire Tilting Motor Works.

    ‎US Well Services Inc (USWS) stock ascended 13.08% at $1.10 in the pre-market trading today after receiving notice from the Nasdaq stock market that it has regained compliance with Nasdaq Listing Rule 5550(b)(2).

    ‎Phunware Inc (PHUN) gained over 21.37% at $1.76 in pre-market ‎trading as Today Phunware COO Randall Crowder will be presenting at the Proactive Investors One2One Investor Forum about the company’s 2021 roadmap for the commercial launch of its blockchain-enabled customer data platform and mobile loyalty ecosystem.

    Top Upgrades & Downgrades

    Goldman Sachs turned bullish on DraftKings Inc. (DKNG), upgrading the stock to “Buy” and assigning a $65.0 price target, representing a potential upside of 26.73% from Monday’s close.

    FVCBankcorp Inc. (FVCB) has won the favor of Piper Sandler’s equity research team. The firm upgraded the shares from Neutral to Overweight and moved their price target to $19.0, suggesting 20.03% additional upside for the stock.

    Colgate-Palmolive Company (CL) received an upgrade from analysts at Berenberg, who also set their one-year price target on the stock to $76.0. They changed their rating on CL to Hold from Sell in a recently issued research note.

    Earlier Tuesday BMO Capital reduced its rating on Sonoco Products Company (SON) stock to Market Perform from Outperform and assigned the price target to $65.

    RBC Capital analysts reduced their investment ratings, saying in research reports covered by the media that it’s rating for BlackBerry Limited (BB) has been changed to Underperform from Sector Perform.

    Analysts at Goldman Sachs downgraded Delek US Holdings Inc. (DK)’s stock to Sell from Neutral Tuesday.

    Latest Insider Activity

    Facebook Inc. (FB) COB and CEO Zuckerberg Mark announced the sale of shares taking place on Jan 22 at $275.79 for some 55,869 shares. The total came to more than $15.41 million.

    Twitter Inc. (TWTR) Engineering Lead Montano Michael sold on Jan 20 a total 664,770 shares at $46.23 on average. The insider’s sale generated proceeds of almost $0.1 million.

    The Blackstone Group Inc. (BX) 10% Owner Blackstone BDC Holdings LLC declared the purchase of shares taking place on Jan 07 at $25.00 for some 997,940 shares. The transaction amount was around $24.95 million.

    Arcadia Biosciences Inc. (RKDA) Chief Executive Officer Plavan Matthew T bought on Aug 03 a total of 14,285 shares at $3.16 on average. The purchase cost the insider an estimated $1,849.

    Important Earnings

    Top US earnings releases scheduled for today include General Electric Company (NYSE: GE). It will announce its Dec 2020 financial results. The company is expected to report earnings of $0.09 per share from revenues of $21.83B in the three-month period.

    Analysts expect Advanced Micro Devices Inc. (NASDAQ: AMD) to report a net income (adjusted) of $0.47 per share when the bank releases its quarterly results shortly. Revenue for the fiscal quarter ended Dec 2020 is predicted to come in at $3.02B.

    Microsoft Corporation (MSFT), due to announce earnings after the market closes today, is expected to report earnings of $1.64 per share from revenues of $40.18B recently concluded three-month period.

  • Adamas Pharmaceuticals (ADMS)revealed board-room changes with the hiring of SpyrosPapapetropoulos

    Adamas Pharmaceuticals (ADMS)revealed board-room changes with the hiring of SpyrosPapapetropoulos

    Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS), a corporation committed to the production and delivery of medications that make a substantial difference to people afflicted by neurological disorders, announced the addition to its Board of Directors of Spyros Papapetropoulos, MD, PhD. With an emphasis on neurology and previously held R&D and clinical leadership positions at Acadia, Cavion, Teva, Pfizer, Allergan, and Biogen, Spyros offers more than 20 years of academic and business experience. Additionally, Adamas confirmed the departure from the Adamas board of Ivan Lieberburg, MD, PhD.

    I’d like to genuinely thank Ivan for his devoted contribution to Adamas. Through numerous successful NDA submissions and Company’s transformation into a successful corporate entity, he played a critical role. We wish him well,’ Adamas Chairman David L. Mahoney said. At this next level of development, we are delighted that Spyros will join us. He would be an excellent addition to our board as a professional research and development leader.

    In addition to his track record of introducing meaningful treatments to the market, Spyros’ vast knowledge in neurodegenerative diseases and movement disorders best suited him to bring an important insight to the board,said Neil F. McFarlane, CEO.

    At this important moment in the journey towards becoming a leading neurology organization, I am pleased to join Adamas,” said Spyros Papapetropoulos. “I look forward very much to being part of the development and continued success of the company.”

    Spyros has led several pharmaceutical research projects during his career, culminating in active regulatory filings and product releases. Spyros has been qualified in London, UK, as a board-certified neurologist and has published more than 160 peer-reviewed publications. Spyros has previously worked on numerous U.S. government and non-profit commissions on progress in healthcare and biomedical research.